The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...

Ozempic is a prescription drug used to deal with conditions related to high blood sugar levels and for diabetes management.

Mounjaro and Ozempic are two medications that can help with diabetes and weight management. But is there a winner in the ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies. Compare side effects here.

For Ozempic, which has seen a slowdown in market growth and a loss in market share, Novo Nordisk plans to focus on commercial efforts to decrease outflow, encourage longer treatment durations, and ...

Mike Schilling. Fentanyl is an extremely potent drug that health experts say only takes a 2mg dose, about the size of five grains of salt, to be deadly. The art exhibit is on display April 30-June ...

Wegovy and Ozempic, both forms of semaglutide manufactured by Novo Nordisk, were on the Food and Drug Administration’s (FDA) shortage list for more than two years. During this period ...

to provide all five dose strengths of its weight-loss GLP-1 medication Wegovy at a reduced cost of $499. All doses will be delivered with a once-weekly single-dose pen. Novo Nordisk’s direct-to ...

single-dose pen. Its list price is $1,349, and the company said that 90% of patients have a co-pay of $0 to $25 per month. In 2024, sales of Wegovy and Novo Nordisk’s other semaglutide products ...

while the single dose pen is available from $25 per month, with doses ranging from 2.5mg to 15mg. Tirzepatide is almost solely responsible for turning Lilly from a ~$150bn market cap company ...

Piperacillin, an antibiotic in the same class as penicillin, effectively cured mice of Lyme disease at 100-times less than the effective dose of doxycycline, the current gold standard treatment.